SLC9A1 and myocardial infarction: This drug protected the heart by suppressing autophagic cell death in cardiomyocytes by inhibiting Na+/H+ exchanger 1 (NHE1), reducing infarct size and myocardial fibrosis, and improving cardiac function in myocardial infarction models [143].